Women with recurrent implantation failure (RIF).
Conditions
Interventions
Intervention group: Patients with recurrent implantation failure (RIF) of immunological origin will receive treatment by a physician. Regarding treatments and dosage, because treatments are individual
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 41 Years
Inclusion criteria
Inclusion criteria: Patients who have experienced at least 2 consecutive implantation failuresPatients who have no history of any type of immunotherapy in their medical history
Exclusion criteria
Exclusion criteria: Patients under 18 years of age and over 41 years of agePatients with coagulation problemsPatients with underlying chronic diseases, including diabetes and high blood pressurePatients with intrauterine anomalies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Women with recurrent implantation failure (RIF) of immunological origin. Timepoint: At the beginning of the study (before the intervention), patients were diagnosed with recurrent implantation failure of immunological origin. Method of measurement: Diagnosis of patients with recurrent implantation failure of immunological origin will be performed by iFertility software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Yousefi
Tabriz University of Medical Sciences
Outcome results
None listed